NCT00001806

Brief Summary

In 1997, the Genetics Department of the NCI Medicine Branch helped establish a breast cancer genetics program at the National Naval Medical Center s Breast Care Center. Genetic education, counseling, and germline testing for BRCA1 and BRCA2, two genes which confer increased lifetime risks for breast and ovarian cancer, were offered under a Navy IRB-approved study. Sixty participants received education and counseling on that protocol, 49 of whom chose to have genetic testing. The education and counseling, provided by oncology nurses trained in cancer genetics, focused on preparing participants to make well-informed decisions about testing. Included were information on cancer and genetics; hereditary breast/ovarian cancer syndrome; risks, benefits and limitations of BRCA1/BRCA2 testing; and screening and risk reduction options for high-risk individuals. Through our experience with this study, we devised two different methods of providing this information. Both of these methods were well received and appear to be equally effective, as measured by knowledge assessments before and after the sessions and subjective evaluation by the participants. We will now study them in a randomized fashion in the current protocol, to better evaluate whether one method is preferable. Ultimately we hope to be able to make recommendations that will allow for access to genetic education and counseling for more individuals in a more cost efficient manner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at below P25 for phase_3 breast-cancer

Timeline
Completed

Started Apr 1999

Longer than P75 for phase_3 breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 6, 1999

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 3, 1999

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 4, 1999

Completed
18.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2017

Completed
Last Updated

December 12, 2019

Status Verified

December 6, 2017

Enrollment Period

18.7 years

First QC Date

November 3, 1999

Last Update Submit

December 11, 2019

Conditions

Keywords

Genetic TestingGenetic CounselingBRCA1/BRCA2Genetic EducationInformed ConsentBreast CancerOvarian CancerKnown Family Mutation

Outcome Measures

Primary Outcomes (2)

  • Impact of Events Scale

    Baseline, 3, 6, and 12 months

  • Breast Cancer Genetics Knowledge Score

    Baseline, 3, 6, and 12 months

Study Arms (2)

Group

EXPERIMENTAL

Group education and counseling

Other: Genetic Education and Counseling

Individual

ACTIVE COMPARATOR

Individual education and counseling

Other: Genetic Education and Counseling

Interventions

Group Education and Counseling

Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least one of the following:
  • Diagnosis of breast cancer, or DCIS prior to or at 45, or ovarian cancer prior to or at age 50;
  • Diagnosis of breast cancer with bilateral disease or multiple primaries or breast cancer and ovarian cancer in the same individual;
  • Diagnosis of breast or ovarian cancer and one first or second degree relative with breast cancer diagnosed prior to or at age 45, or ovarian cancer prior to or at age 50;
  • Diagnosis of breast or ovarian cancer and three relatives in the same lineage with breast or ovarian cancer; each affected individual must be a first- or second-degree relative to another of the affected individuals;
  • Diagnosis of breast or ovarian cancer and a first or second degree male relative with breast cancer;
  • A woman of Ashkenazi Jewish descent who meets any of the above criteria, with specified ages of onset of 50 for breast cancer and any age for ovarian cancer;
  • A male with breast cancer diagnosed at any age;
  • Documented BRCA mutation in the family.
  • All individuals must be able to give informed consent.

You may not qualify if:

  • Patients will be considered ineligible for any of the following reasons:
  • Any psychological disorder which may hinder the participant's ability to understand and process the material, based on a psychiatric consultation.
  • Inable to return for 2 visits.
  • Age under 18 years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Walter Reed National Medical Center

Bethesda, Maryland, 20301, United States

Location

Related Publications (3)

  • Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol. 1996 May;14(5):1730-6; discussion 1737-40. doi: 10.1200/JCO.1996.14.5.1730.

    PMID: 8622094BACKGROUND
  • Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet. 1994 Nov;55(5):i-iv. No abstract available.

    PMID: 7977337BACKGROUND
  • Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA. 1995 Feb 15;273(7):577-85.

    PMID: 7837392BACKGROUND

MeSH Terms

Conditions

Breast NeoplasmsOvarian NeoplasmsFanconi Anemia, Complementation Group D1

Interventions

Counseling

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesEndocrine Gland NeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Kathleen Calzone, R.N.

    National Cancer Institute (NCI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 1999

First Posted

November 4, 1999

Study Start

April 6, 1999

Primary Completion

December 6, 2017

Study Completion

December 6, 2017

Last Updated

December 12, 2019

Record last verified: 2017-12-06

Locations